Non-Current Assets
Deferred Tax Assets and Other Non-Current Assets
West Pharmaceutical Services Deferred Tax Assets and Other Non-Current Assets increased by 1.5% to $81.30M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 15.8%, from $70.20M to $81.30M. Over 5 years (FY 2020 to FY 2025), Deferred Tax Assets and Other Non-Current Assets shows an upward trend with a 27.9% CAGR.
Analysis
StatementBalance Sheet Statement
SectionNon-Current Assets
CategoryLiquidity
SignalContext dependent
VolatilityStable
First reportedQ4 2014
Last reportedQ4 2024
How to read this metric
An increase generally reflects a growing long-term asset base or deferred tax position, while a decrease suggests asset liquidation or tax benefit utilization.
Detailed definition
This is the aggregate balance of non-current deferred tax assets and other miscellaneous non-current assets not classifi...
Peer comparison
Commonly found in the non-current asset section of balance sheets for large, diversified financial firms.
Metric ID:
deferred_tax_assets_other_noncurrentHistorical Data
20 periods
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $26.30M | $31.60M | $39.20M | $40.50M | $49.40M | $52.70M | $38.40M | $36.70M | $40.30M | $38.80M | $21.30M | $19.00M | $50.10M | $69.30M | $74.30M | $70.20M | $70.50M | $75.80M | $80.10M | $81.30M |
| QoQ Change | — | +20.2% | +24.1% | +3.3% | +22.0% | +6.7% | -27.1% | -4.4% | +9.8% | -3.7% | -45.1% | -10.8% | +163.7% | +38.3% | +7.2% | -5.5% | +0.4% | +7.5% | +5.7% | +1.5% |
| YoY Change | — | — | — | — | +87.8% | +66.8% | -2.0% | -9.4% | -18.4% | -26.4% | -44.5% | -48.2% | +24.3% | +78.6% | +248.8% | +269.5% | +40.7% | +9.4% | +7.8% | +15.8% |
Range$19.00M – $81.30M
CAGR+26.8%
Avg YoY Growth+43.8%
Median YoY Growth+12.6%
Current Streak4 quarters growth
Deferred Tax Assets and Other Non-Current Assets at Other Companies
Frequently Asked Questions
- What is West Pharmaceutical Services's deferred tax assets and other non-current assets?
- West Pharmaceutical Services (WST) reported deferred tax assets and other non-current assets of $81.30M in Q1 2026.
- How has West Pharmaceutical Services's deferred tax assets and other non-current assets changed year-over-year?
- West Pharmaceutical Services's deferred tax assets and other non-current assets increased by 15.8% year-over-year, from $70.20M to $81.30M.
- What is the long-term trend for West Pharmaceutical Services's deferred tax assets and other non-current assets?
- Over 5 years (2020 to 2025), West Pharmaceutical Services's deferred tax assets and other non-current assets has grown at a 27.9% compound annual growth rate (CAGR), from $23.40M to $80.10M.
- What does deferred tax assets and other non-current assets mean?
- The total value of long-term tax assets and other miscellaneous long-term assets.